BHVN

Biohaven Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 0/10
  • Value 4/10
Biohaven sales and earnings growth
BHVN Growth
Low
  • Revenue Y/Y 0.00%
  • EPS Y/Y 26.08%
  • FCF Y/Y -4.03%
Biohaven gross and profit margin trends
BHVN Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC 5Y -262.02%
Biohaven net debt vs free cash flow
BHVN Risk
Poor
  • Debt / Equity 5.4
  • Debt / FCF 0.1
  • Interest coverage 999.0

Biohaven stock volatility is in-line with the overall market. We give it a Poor risk rating.

More Biotechnology stocks ↗